Can a Funder Review a Manuscript Before Publication?

Can you show a manuscript to the research sponsor before sending it to a journal?

A company funds your study and asks to see the manuscript before you submit it. Perhaps the sponsor wants to check whether proprietary information has been included, identify an invention that should be patented, verify factual descriptions of its product, or simply comment on how the results are presented.

Is allowing that review compatible with research independence?

It can be. The important distinction is between giving a sponsor an opportunity to review and comment and giving that sponsor authority to approve, rewrite, suppress, or indefinitely postpone publication.

Prepublication review can be acceptable if researchers retain publication authority

The key distinction is review versus approval

A sponsor can have legitimate reasons to see a manuscript

Sponsored research can involve information that requires attention before public disclosure. A manuscript may reveal a potentially patentable invention, contain information supplied by the sponsor under a confidentiality agreement, inaccurately describe a proprietary technology, or inadvertently disclose information that the research agreement legitimately protects.

A limited prepublication review period can allow these issues to be identified without transferring scientific control of the manuscript to the sponsor.

Institutional policies illustrate how such arrangements can work. Stanford University, for example, permits sponsored-research agreements to provide a short publication delay, not exceeding 90 days under its policy, for patenting purposes or sponsor review and comment, provided there was no expectation that the sponsor would attempt to suppress publication or impose substantive changes. This is an institutional rule, not a universal 90-day standard.

Review is different from requiring permission to publish

The most important contractual question is what happens after the sponsor has read the manuscript.

These arrangements are not equivalent. A right to comment preserves the possibility of disagreement. A right to approve can make the sponsor the final gatekeeper of the scientific record.

Current publication guidance strongly protects author independence

ICMJE states that authors should avoid agreements with study sponsors, whether for-profit or nonprofit, that interfere with access to study data or with authors' ability to analyze and interpret those data and prepare and publish manuscripts independently when and where they choose. It also states that policies dictating where authors may publish violate academic freedom.

ICMJE recommends that articles report the sponsor's role in study design, data collection, analysis and interpretation, writing, and any restrictions regarding submission for publication. Editors may request research agreements confidentially when necessary to assess those arrangements.

Current ICMJE guidance therefore focuses less on whether a sponsor ever sees the manuscript and more on whether authors remain genuinely capable of publishing independently.

Commenting on a manuscript does not give the sponsor authorship authority

A sponsor may suggest that a sentence is factually inaccurate, request clarification, challenge an interpretation, or propose an alternative analysis. Researchers should consider scientifically legitimate comments regardless of who makes them.

But the sponsor's financial contribution does not give it automatic authority to dictate the conclusions. Investigators remain responsible for the accuracy and integrity of the manuscript carrying their names.

If a sponsor identifies a genuine error, researchers should correct it. If the sponsor simply dislikes an unfavorable but defensible interpretation, researchers should not be required to replace it with a commercially preferable one.

Sponsor employees who qualify as authors are different from sponsor review

Some sponsored studies include legitimate authors who are employees of the sponsoring organization. If those individuals satisfy the journal's authorship criteria, they should participate in drafting and revising the manuscript like other authors and accept the corresponding accountability.

That situation should not be confused with a separate corporate approval process. An author employed by the sponsor can contribute scientifically to the paper. A company office claiming authority to veto the collective authors' publication is a different arrangement.

Patent review can justify a limited delay

Public disclosure of an invention can affect patent rights, with the legal consequences depending on jurisdiction. Sponsored-research agreements therefore commonly provide a short review period so potentially patentable material can be identified and appropriate filings considered.

Historically, ICMJE editors have explicitly recognized that a sponsor may have a legitimate opportunity to review a manuscript for a defined period for patent protection while opposing contractual arrangements that allow the sponsor to withhold publication. Stanford's current research policy similarly permits a limited delay for patenting or sponsor review.

The important feature is that the delay has a defined purpose and endpoint. Patent protection should not become a convenient label for indefinite suppression.

Confidential information requires careful definition

A sponsor may legitimately provide proprietary information that researchers agree to keep confidential. A manuscript should not casually publish information that falls within a valid confidentiality obligation.

However, research agreements should distinguish sponsor-provided confidential information from the research findings themselves. If every unfavorable result can be redesignated “confidential,” the confidentiality clause effectively becomes a publication veto.

Researchers and their institutions should therefore scrutinize how confidential information is defined before signing the agreement, not only when a manuscript is ready for submission.

The sponsor can disagree without controlling the final interpretation

Scientific disagreement between investigators and sponsors is not inherently problematic. A sponsor may reasonably believe the authors have interpreted a finding incorrectly. Researchers should evaluate that argument on its merits.

But disagreement should not silently become censorship. Investigators should retain the ability to report scientifically defensible findings even when the sponsor disagrees with the results or interpretation.

Prepublication review should be negotiated before the research starts

The worst time to discover that a sponsor claims manuscript approval rights is after the study produces an unfavorable result.

Publication provisions should therefore be examined during contract negotiation. Researchers and their institutions should determine who may review manuscripts, how long review lasts, what information can legitimately be removed or delayed, whether sponsor comments are advisory, and who ultimately decides whether the manuscript is submitted.

This also makes the distinction between a limited publication delay and a sponsor's power to prevent publication much easier to identify before either becomes a practical problem.

Journal editors may want to know about sponsor restrictions

ICMJE encourages editors, as part of peer review, to examine protocols, statistical analysis plans, and contracts associated with project-specific studies where appropriate. It also permits journals to request sponsor agreements confidentially.

This reflects an important principle: readers and editors need to know whether the apparent academic authors actually had sufficient control over the research and publication process to take responsibility for the paper.

When sponsor review is acceptable and when it becomes control

Now change the final condition: the agreement says the manuscript cannot be submitted without written sponsor approval. That is no longer merely a prepublication review right. The sponsor possesses a publication veto.

Common mistakes about sponsor manuscript review

Negotiate the sponsor's manuscript rights before signing the agreement

Do not focus only on the research budget. Publication clauses determine what happens when the findings become inconvenient, which is precisely when publication independence matters most.

A useful contract should make it possible to answer one simple question before the study begins: after legitimate review requirements are satisfied, can the researchers publish the results even if the sponsor wishes they would not?

What should you check in a sponsor manuscript-review clause?

Frequently asked questions about sponsor review before publication

A sponsor may review your manuscript without owning the decision to publish it

How to Cite This Guide

This guide is intended to be read, shared, and used in research, teaching, and academic work. If you draw on its ideas, explanations, or other content, please acknowledge the source by citing the guide. Doing so gives appropriate credit and helps your readers locate the original resource.